Here's Why MP Materials Stock Surged Higher This Week The rare-earth materials and magnets company's strategic importance to the U.S. was reinforced recently.
Nvidia Stock Investors Must Learn About This One Big Strategy Shift Understanding key strategic inflection points is critical for investing success.
Novo Nordisk Stock Investors Get Huge News on Drug Trial Results Investors will want to see these key developments concerning Novo Nordisk's pipeline of new treatments.
Why Did Tesla Stock Jump 10% This Week? Elon Musk gave investors more insight into Tesla's AI future.
Why Did Intel Stock Pop Friday? Buying Intel stock on today's news doesn't make much sense.
Is First Interstate Stock a Buy or Sell After One of the Board of Directors Dumps Shares Worth Nearly $1 Million? This regional bank with a strong dividend and community focus reported notable insider selling following a year of modest stock declines.
Salesforce Data Shows $8.4B Thanksgiving Spend In US Driven By Bargain Hunters According to Salesforce, Thanksgiving accounted for $35.6 billion in digital sales around the world, up 6% year-over-year.
Amazon Stock Rallies Past Key Level On Black Friday. Thanksgiving Was Heavy On Discounts. Amazon stock was higher Friday as shoppers geared up for what analysts say will be a record-setting Black Friday.
Why Tilray Stock Just Stubbed Out In a clear sell signal, Tilray will reverse split its stock next week.
NXTT Stock Surged 60% Today – What’s The Bitcoin Angle? Next Technology’s unit, Next Investment Group, signed an MoU with Global Nexgen to explore a potential Bitcoin-related deal.
CF Industries: Deep Value In A Cyclical Fertilizer Leader CF Industries operates a portfolio of world-class nitrogen manufacturing complexes strategically located in the U.S. and the U.K., with strong advantages in scale, low-cost natural gas feedstock, and export access.
Here's Why Imperial Petroleum (IMPP) Stock Is Trending Friday Imperial Petroleum shares are trading lower Friday after the company announced the pricing of a $60 million registered direct offering.
AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.
